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Burst suppression is an EEG pattern characterized by alternating periods of high-amplitude
activity (bursts) and relatively low amplitude activity (suppressions). Burst suppression can
arise from several different pathological conditions, as well as from general anesthesia.
Here we review current algorithms that are used to quantify burst suppression, its various
etiologies, and possible underlying mechanisms. We then review clinical applications of
anesthetic-induced burst suppression. Finally, we report the results of our new study
showing clear electrophysiological differences in burst suppression patterns induced by
two common general anesthetics, sevoflurane and propofol. Our data suggest that the
circuit mechanisms that generate burst suppression activity may differ among general
anesthetics.
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INTRODUCTION
Burst suppression is an EEG pattern characterized by quasiperi-
odic high amplitude activity (bursts) and relativity low amplitude
activity (suppressions; Amzica, 2009; Brown et al., 2010). The
phenomenon was first observed while recording EEG from the
motor cortex of cats under tribromoethanol and pentobarbital-
induced general anesthesia (Derbyshire et al., 1936). Investiga-
tions into the effects of ether and pentobarbital anesthesia on
the EEG of canines led to the creation of the term “burst sup-
pression” (Swank and Watson, 1949). Although early work on
burst suppression focused on general anesthesia, burst suppres-
sion can be induced by several different etiologies (Martin et al.,
1959).
In the first part of this article, algorithms employed to
quantify burst suppression, different causes of burst suppres-
sion, and theories about the mechanisms underlying burst sup-
pression are reviewed. We also describe clinical applications of
burst suppression induced by general anesthetics. In the sec-
ond part of this article, we present original research findings
from our laboratory that demonstrate the distinct electrophys-
iological characteristics of burst suppression induced by the
inhaled anesthetic sevoflurane and the intravenous anesthetic
propofol.
QUANTIFICATION OF BURST SUPPRESSION
A widely used method for quantifying burst suppression is the
burst suppression ratio (BSR; Rampil et al., 1988). Figure 1
shows several seconds of EEG burst suppression from a rodent
anesthetized with isoflurane. The BSR is calculated by segment-
ing the EEG into bursts and suppressions using a voltage-based
threshold. Suppression is commonly defined as a voltage less
than 5 µV for greater than 0.5 s. This threshold is commonly
set manually (Chemali et al., 2011) though automated meth-
ods such as a time-domain based voltage envelope threshold
or frequency-domain based logistic regression of the EEG spec-
trogram have also been reported. (Prerau and Purdon, 2013;
Westover et al., 2013). For the BSR algorithm, suppressions are
given a value of 1 and bursts are given a value of 0 to create
a binary time-series. This binary time-series is then smoothed
with a windowing function to calculate the BSR over time.
The value of the BSR ranges from 0 and 1, with 0 indicating
no suppression and 1 indicating a suppressed EEG. Although
the BSR can be derived with relative ease, the temporal res-
olution/smoothness of the result depends on the size of the
time windows, which must be chosen manually, and the inabil-
ity to obtain a measure of confidence around BSR estimates
makes it difficult to perform statistical comparisons between
BSR values at different points in time. Currently available EEG-
based anesthetic depth monitors usually detect and quantify the
BSR.
The burst suppression probability (BSP) is an alternate
approach to model the level of burst suppression (Chemali et al.,
2013). The BSP is based on a state-space model of the brain state
of burst suppression, and represents the instantaneous probability
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FIGURE 1 | A typical EEG recording showing a burst suppression pattern from a rodent undergoing general anesthesia from isoflurane. The sampling
rate of the signal was 512 Hz and a line filter was used to eliminate 60 Hz noise.
of the brain being in a suppressed state. In contrast to the BSR,
principled automated methods have been developed for setting
the BSP algorithm parameters and the resulting temporal reso-
lution/smoothness of the estimated BSP, and they also allow for
statistical comparisons of the level of suppression across different
points in time. Entropy measures such as approximate entropy
(Bruhn et al., 2000, 2001) and machine learning methods such
as artificial neural networks or support vector machines (Löfhede
et al., 2007) have also been used to quantify burst suppression.
PATHOLOGICAL CAUSES OF BURST SUPPRESSION
There are several known pathological conditions that cause
EEG burst suppression. Early work with animals demonstrated
that local freezing of cortical sections from cats with carbon
dioxide led to profoundly decreased electrical activity, both in
frozen and unfrozen areas of the brain, and that rewarming
led to partial recovery of electrical activity (Nims et al., 1941).
In humans, lowering of the core body temperature has been
shown to linearly decrease the overall spectral power of the
EEG (Levy, 1984), and burst suppression is often observed in
humans with temperatures below 24.4◦C (Stecker et al., 2001).
Hypothermia reduces the cerebral metabolic rate, and is often
used to provide neuroprotection in patients with circulatory
arrest (Michenfelder and Milde, 1991; Arrica and Bissonnette,
2007).
Hypoxia is a common pathological cause of burst suppression.
In animal experiments, hypoxia has been shown to induce burst
suppression as well as a suppressed EEG at extremely low arterial
oxygen concentrations in dogs (Spoerel, 1961). G-force induced
hypoxia in rodents has also induced burst suppression (Lukatch
et al., 1997). In humans, fetal hypoxia during labor and delivery
can lead to hypoxic-ischemic encephalopathy in the neonate and
induce burst suppression patterns in the EEG (Toet et al., 1999;
van Rooij et al., 2005). While recovery from burst suppression
can occur within the first 48 h after birth, the appearance of
burst suppression usually portends a poor prognosis for the
neonate (Grigg-Damberger et al., 1989; Hellström-Westas et al.,
1995).
Patients suffering from coma may exhibit EEG burst suppres-
sion due to several different underlying etiologies (Young, 2000).
Post-anoxic coma (Zaret, 1985) can induce a rare burst suppres-
sion pattern where the burst patterns are identical (Hofmeijer
et al., 2014). In addition, burst suppression has been described
in a survivor of post-anoxic coma during behaviorally defined
sleep (i.e., eyes closed with no movement) (Kheder et al., 2014).
Burst suppression may also be observed when patients are in coma
due to hepatic failure (Bickford and Butt, 1955), sepsis (Young
et al., 1992) and hypoglycemia (Auer et al., 1984). Coma due to
porphyria, a disorder of heme synthesis (Thadani et al., 2000),
can also elicit a burst suppression pattern (Dow, 1961).
Ohtahara syndrome, an early infantile epilepsy syndrome,
is characterized by a burst suppression pattern that persists
through behaviorally defined wake and sleep states (Ohtahara
and Yamatogi, 2006). Typically Ohtahara syndrome manifests
itself within 3 months of birth, and is thought to be caused
by structural brain lesions. Patients with Ohtahara syndrome
have been reported to have lesions of the thalamus, hippocam-
pus, and brainstem tegmentum (Itoh et al., 2001; Ohtahara
and Yamatogi, 2003). Early myoclonic encephalopathy is another
infantile epilepsy syndrome that results in a persistent burst
suppression pattern, usually manifesting itself during the neonatal
period (Aicardi and Ohtahara, 2005). Unlike Ohtahara syndrome,
early myoclonic encephalopathy is hypothesized to be due to an
underlying metabolic disorder (Panayiotopoulos, 2010).
Another disorder that causes burst suppression is Aicardi
syndrome, a congenital disorder in which the corpus callosum
fails to develop in female infants (Fariello et al., 1977; Aicardi,
2005).In patients with a damaged corpus callosum that undergo
general anesthesia, burst suppression patterns have been reported
to be asymmetric and asynchronous across cerebral hemispheres
(Lambrakis et al., 1999; Lazar et al., 1999).
Finally, various medications and intoxicants that are not used
for general anesthesia may induce burst suppression at high
doses, including ethanol (Whishaw, 1976), the muscle relaxant
baclofen (Weissenborn et al., 1991; Ostermann et al., 2000), and
the anticonvulsant carbamazepine (De Rubeis and Young, 2001).
A recent report described burst suppression in a patient suffering
from an overdose of bupropion (Mundi et al., 2012), which is used
to treat depression and nicotine addiction.
BURST SUPPRESSION INDUCED BY GENERAL ANESTHETICS
General anesthetics are administered by inhalation or intravenous
injection. The main molecular targets for general anesthetics
are thought to be gamma-aminobutyric acid type A (GABAA)
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receptors and N-methyl D-aspartate (NMDA) receptors (Solt
et al., 2006; Brown et al., 2011), although many other targets have
been identified that likely play a role in general anesthesia as well.
The halogenated ethers enflurane (Lebowitz et al., 1972), isoflu-
rane (Hartikainen et al., 1995b), sevoflurane (Scheller et al., 1990)
and desflurane (Rampil et al., 1991) all induce burst suppression
at sufficiently high doses. However, the haloalkane general anes-
thetics chloroform (Pearcy et al., 1957) and halothane (Murrell
et al., 2008) have not been reported to induce burst suppression,
even at high concentrations that produced suppression.
Barbiturates are intravenous anesthetics that primarily act
by potentiating the function of GABAA receptors. Pentobar-
bital (Van Ness, 1990), methohexital (Wennberg et al., 1997),
and sodium thiopental (Kassell et al., 1980) are all barbi-
turates that have been shown to induce burst suppression.
Propofol (Huotari et al., 2004) and etomidate (Modica and
Tempelhoff, 1992) are not barbiturates, but they also act pri-
marily by enhancing GABAA receptor function, and also induce
burst suppression. 13–15 Hz spindle activity, similar to that
seen during NREM sleep, has been seen during both the
burst and suppression phase of propofol-induced burst sup-
pression (Särkelä et al., 2002; Huotari et al., 2004; Ferenets
et al., 2006). Sharp waves resembling the vertex waves seen
during NREM sleep have also been observed during the bursts
and suppressions phases from propofol-induced burst suppres-
sion. These spindles and sharp waves are theorized to have
been produced by the sensorimotor cortex (Sonkajärvi et al.,
2008).
Gaseous anesthetics such as xenon or nitrous oxide that are
NMDA receptor antagonists have not been shown to induce burst
suppression, even at high doses in a hyperbaric chamber (Morris
et al., 1955; Pittinger et al., 1955). Similarly, the intravenously
administered NMDA receptor antagonist ketamine has not been
shown to elicit burst suppression (Barash et al., 2012). However,
the gaseous anesthetic cyclopropane, which is also an NMDA
receptor antagonist (Solt et al., 2006), has been shown to induce
burst suppression (Possati et al., 1953).
In summary, most general anesthetics that act primarily by
enhancing GABAA receptors induce burst suppression, whereas
NMDA antagonists typically do not. However, there are excep-
tions to both rules, suggesting that molecular mechanisms alone
cannot account for general anesthetic-induced burst suppression.
MECHANISMS OF BURST SUPPRESSION INDUCED BY GENERAL
ANESTHESIA
Intracellular recordings of cortical and subcortical neurons laid
the early groundwork for investigations into the mechanisms of
burst suppression. While the majority of cortical cells exhibit
a pattern of alternating depolarized and hyperpolarized states
that account for the burst suppression pattern observed in the
electrocorticogram, thalamic cells are either silent or fire at 1–4 Hz
under general anesthesia (Steriade et al., 1994).
During moderate to deep levels of isoflurane anesthesia that
induce burst suppression, external mechanical, visual, and audi-
tory stimuli have been shown to trigger bursts (Yli-Hankala
et al., 1993a; Hartikainen et al., 1995b; Hudetz and Imas, 2007;
Amzica, 2009). Therefore, burst suppression has been considered
a state of cortical hypersensitivity (Kroeger and Amzica, 2007),
although external stimuli fail to induce bursting at isoflurane
levels less than 2%, or greater than 3.5% (when the EEG is com-
pletely suppressed; Kroeger and Amzica, 2007). These findings
suggest that the brain is still receptive to external stimuli during
anesthetic-induced burst suppression. The recording of heart rate
during externally triggered bursts did not show any overt changes,
suggesting the effect is not derived from the autonomic nervous
system (Kroeger and Amzica, 2007).
The state of cortical hypersensitivity during burst suppres-
sion is thought to be due to changing calcium levels and
the lowering of cortical inhibition by isoflurane (Kroeger and
Amzica, 2007; Ferron et al., 2009). Increasing the dose of isoflu-
rane steadily lowered the amount of extracellular calcium until
a state of burst suppression was reached. During burst sup-
pression the levels of extracellular calcium decreased during
bursts, and began to increase throughout the suppression period.
Triggered bursts were more easily induced by external stim-
uli when sufficient time had elapsed after the previous stim-
ulus, suggesting that a refractory period exists during which
the extracellular calcium must reach a threshold level before a
subsequent burst can be induced (Kroeger and Amzica, 2007).
Administration of the NMDA antagonist MK801 significantly
diminished both the amplitude and duration of bursts, but
did not alter the probability of inducing a triggered burst by
an external stimulus. The gap junction blocker carbenoxolone
completely eliminated any triggered response, suggesting that
in addition to extracellular calcium, NMDA receptors and gap
junctions may also regulate the response (Kroeger and Amzica,
2007).
Phenomenological modeling of burst suppression has been
performed using non-linear dynamic systems and dynamic mean
field models. Modeling using chaos theory and non-linear systems
for human coma patients showed that burst frequency decreased
logarithmically as burst durations increased (Rae-Grant and Kim,
1994). Mesoscopic modeling using a dynamic mean field model
suggested that multiple origins of burst suppression exist through
several different slow modulating circuits (Liley and Walsh,
2013).
An alternative to the phenomenological models is a neuro-
metabolic model, which accounts for the different etiologies that
lead to burst suppression activity (Ching et al., 2012). The under-
lying process of burst suppression is viewed as a reduction in brain
metabolism, as it is known that hypothermia, hypoxia, Ohtahara
syndrome, and general anesthetics that act as GABAA agonists
all decrease the cerebral metabolic rate of oxygen (CMRO). The
reduction of the CMRO further lowers the production rate of
adenosine triphosphate, and increases cell membrane conduc-
tance. In response to lowered ATP production and increased
conductance, an ATP-gated potassium channel expressed in cor-
tical and subcortical neurons hyperpolarizes to prevent cell firing
and preserve a lower energy state. This inhibition of bursting
activity directly leads to the suppression period observed dur-
ing burst suppression. As the suppression persists, ATP levels
begin to recover and membrane conductance is lowered until
another burst can occur. If the cerebral metabolic rate continues
to decrease, the suppression periods will be prolonged until all
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FIGURE 2 | An intracranial recording from the cortex of an epileptic patient under propofol general anesthesia. The burst in channel 32 starts hundreds
of milliseconds before the bursts in channels 36 and 34, demonstrating that burst onset is heterogeneous across the cortex. The signal was low-passed filtered
at 100 Hz and resampled to 250 Hz. From (Lewis et al., 2013).
bursting has ceased. This can be seen with increasing doses
of general anesthetics—as the anesthetic continues to depress
the cerebral metabolic rate, the EEG eventually becomes sup-
pressed. Lowered ATP production could also lead to an impair-
ment of calcium pumps and lead to a decrease in extracellular
calcium.
This neuro-metabolic model predicts that the spectral content
within bursts for a human patient undergoing propofol anesthesia
will be limited to a frequency of around 10 Hz (alpha rhythm),
and that this alpha rhythm can drift from having a peak power at
10 Hz at the beginning of a burst to having a peak power at 8 Hz
at the end of a burst. In addition, it is thought that the spectral
content of bursts reflects the neurophysiological state that was
present immediately preceding burst suppression (Ching et al.,
2012).
Data from human patients undergoing propofol anesthesia
support this neuro-metabolic model (Lewis et al., 2013). High-
density cortical recordings also revealed that burst suppression
activity is not a cortex-wide phenomenon as once thought. While
some regions of the cortex may be in burst suppression, other
regions may not be. The occurrence of bursts can also be limited
locally to discrete cortical regions. Figure 2 shows how bursts can
also be spatially asynchronous across the cortex, with adjacent
cortical areas having similar burst timings compared to anatomi-
cally distant areas (Lewis et al., 2013). This phenomenon was also
noted in earlier human experiments (Henry and Scoville, 1952).
CLINICAL APPLICATIONS OF ANESTHETIC-INDUCED BURST
SUPPRESSION
Status epilepticus is a state of persistent seizure activity that
can last for several hours or even days (Lowenstein et al.,
1999), with a mortality rate of up to 35% (Prasad et al., 2001).
When status epilepticus is refractory to other therapies, seizure
activity is often terminated by inducing burst suppression with
intravenous general anesthetics such as propofol (Stecker et al.,
1998; Prasad et al., 2001) or pentobarbital (Van Ness, 1990;
Claassen et al., 2002). When treating status epilepticus, burst
suppression is typically maintained by manually titrating an
intravenous infusion of general anesthetic to a target BSR value.
Automated closed-loop anesthesia delivery (CLAD) systems have
been proposed to deliver propofol (Vijn and Sneyd, 1998) and
etomidate (Cotten et al., 2011) using the BSR as the control
signal. Recently, CLAD systems using the BSP as the control
signal have been developed to deliver intravenous propofol in
rats (Ching et al., 2013; Shanechi et al., 2013a,b), and these
have been shown to achieve precise control of the level of burst
suppression, obviating the need for manual titration of drug
delivery. Figure 3A shows the closed-loop design of one of
these CLAD systems. Figure 3B shows the process for online
segmentation of the EEG for calculating the BSP, and Figure 3C
shows the compartment model used to control the propofol
infusion rate. Anesthetic-induced burst suppression is also used
to treat patients suffering from traumatic brain injury with ele-
vated intracranial pressures (Doyle and Matta, 1999), as well
as patients suffering from severe depression (Engelhardt et al.,
1993).
A STUDY TO COMPARE THE BURST SUPPRESSION CHARACTERISTICS
OF TWO GENERAL ANESTHETICS
Burst suppression is typically regarded as a neurophysiologi-
cal phenomenon that may be caused by a range of etiolo-
gies. However, earlier experiments showed that volatile and
intravenous anesthetics may have distinct electrophysiological
characteristics during burst suppression. A study in rats com-
paring the EEG characteristics of isoflurane and propofol found
significant differences between burst duration and peak-to-peak
voltage at an equivalent BSR of 0.8 (Akrawi et al., 1996). How-
ever, the duration of the suppression and burst epochs that
were compared were only 2–6 s. A study in rabbits compar-
ing 1 min each of EEG burst suppression during propofol
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and isoflurane anesthesia reported higher amplitude bursts dur-
ing isoflurane anesthesia (Hartikainen et al., 1995a). Another
comparison between the burst suppression patterns of isoflurane
and enflurane found that suppressions were shorter in duration
for enflurane (Lipping et al., 1995). Burst suppression caused
by hypoxic-ischemic encephalopathy has also been reported to
have a higher variability in individual suppression durations
compared to pentobarbital-induced burst suppression (Beydoun
et al., 1991).
Although these reports suggest that different general anesthet-
ics and pathological states may induce distinct burst suppression
patterns, a systematic study comparing a large number of bursts
and suppressions induced by two different anesthetics across all
levels of burst suppression has not been performed previously.
In this study, we induced different levels of burst suppression in
rats with the inhaled anesthetic sevoflurane and the intravenous
anesthetic propofol, and quantified the level of burst suppression
using BSP. A large number of bursts and suppressions (n > 2000)
were compared to analyze the electrophysiological characteristics
of burst suppression induced by sevoflurane and propofol. We
found that the durations, peak-to-peak amplitudes, and spec-
tral power of the bursts and suppressions differed substantially
between the two anesthetics at equivalent BSP levels, suggest-
ing that at least some aspects of the mechanisms underlying
burst suppression induced by sevoflurane and propofol may be
distinct.
METHODS
ANIMAL CARE AND USE
All animal studies were approved by the Institutional Animal
Care and Use Committee (IACUC) at Massachusetts General
Hospital, Boston, Massachusetts. Four male Sprague-Dawley rats
(Charles River Laboratories, Wilmington, MA) weighing between
550–670 g were used for these studies. Animals were provided
at least 3 days of rest between experiments. Animals were kept
on a standard day-night cycle (lights on at 7:00 AM, and off at
7:00 PM), and all experiments were performed during the day.
SURGICAL PLACEMENT OF ELECTROENCEPHALOGRAPHY (EEG)
EXTRADURAL ELECTRODES AND RECORDING
Rats were surgically implanted with extradural electrodes at least
7 days before experiments using previously described methods
(Solt et al., 2011; Chemali et al., 2012; Ching et al., 2013). Elec-
troencephalography was performed with a sampling frequency of
500 Hz using a QP511 Quad AC Amplifier System (Grass Instru-
ments, West Warwick, RI), and a USB-6009 14-bit data acqui-
sition board (National Instruments, Austin, TX). The electrical
potential between stereotactic coordinates (relative to lambda)
A0L0 and A6L-3 (left somatosensory cortex) was recorded. A line
filter with cutoff frequencies of 0.3–50 Hz was used, and the signal
was downsampled to 50 Hz.
PREPARATION AND DELIVERY OF DRUGS
Sevoflurane was obtained from Sigma-Aldrich (St. Louis, MO),
and propofol (containing intralipid) was obtained from APP
Pharmaceuticals (Schaumburg, IL). For the delivery of the intra-
venous anesthetic propofol, rats (n = 4) were anesthetized
FIGURE 3 | A brain machine interface (BMI) system to control
propofol-induced burst suppression. (A) The BMI records the EEG,
segments the signal into a binary time-series by filtering and thresholding,
estimates the BSP or equivalently the effect-site concentration level based
on the binary-time series, and then uses this estimate as feedback to
control the propofol infusion rate. (B) A sample EEG trace showing burst
suppression. The top panel shows the EEG signal, the middle panel shows
the corresponding filtered EEG magnitude signal (orange) and threshold
(blue) used to detect the burst suppression events, and the bottom panel
shows the corresponding binary time-series with black indicating
suppression events and white indicating burst events. (C) The
two-compartmental model used by the BMI to characterize the effect of
propofol on the EEG. The EEG was sampled at 500 Hz and the binary
sequence was created by low-pass filtering the EEG at 5 Hz and
thresholding. From (Shanechi et al., 2013b).
in an induction chamber with 2.0–3.0% isoflurane in oxy-
gen. A 24-gauge intravenous catheter was placed in the lateral
tail vein. Isoflurane was then discontinued, and the rat was
removed from the chamber. After the rat fully recovered
from isoflurane anesthesia, propofol was delivered using a
Physio 22 syringe pump (Harvard Apparatus, Holliston, MA)
until loss of righting occurred, at which time the EEG leads
were attached and a rectal temperature probe was inserted.
A heating pad was placed underneath the animal and used
to maintain the core body temperature between 36.5◦ and
37.5◦C.
For delivery of the volatile anesthetic sevoflurane, rats were
initially anesthetized in an induction chamber with 5.0–6.0%
sevoflurane in oxygen. After loss of righting occurred, EEG leads
were attached and a rectal temperature probe was inserted. The rat
was then placed inside a custom built anesthetizing chamber with
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ports for anesthetic gas delivery, scavenging, and gas sampling.
A heating pad was placed underneath the chamber and used to
maintain a core body temperature between 36.5◦ and 37.5◦C.
Sevoflurane concentrations were sampled and monitored from
the distal end of the chamber using an Ohmeda 5250 anesthetic
agent analyzer (GE Healthcare, Waukesha, WI).
EEG RECORDING OF PROPOFOL-INDUCED BURST SUPPRESSION
EEG data for propofol-induced burst suppression was taken from
a previous study by our group that used a CLAD system to
establish and maintain targeted BSP values using propofol (Ching
et al., 2013). For this experiment, the BSP levels of 0.4, 0.65,
and 0.9 were targeted in each rat (n = 4). Each BSP level was
maintained with propofol for at least 15 min, with 10-minute
ramps to transition to new BSP levels. The system used custom
software initialized with MATLAB (Mathworks, Natick, MA)
and issued commands to a Physio 22 syringe pump (Harvard
Apparatus, Holliston, MA) using an RS-232 serial connector.
The typical duration of each experiment was between 80 and
90 min. For this study, we selected 1000 s of artifact-free EEG data
from each rat to provide direct comparisons with sevoflurane-
induced burst suppression at equivalent BSP values in the same
animals.
EEG RECORDING OF SEVOFLURANE-INDUCED BURST SUPPRESSION
For sevoflurane-induced burst suppression recordings, the same
rats (n = 4) from the propofol CLAD study were used. Once the
animal was in the anesthetizing chamber, the dose of sevoflurane
was initially set at 3.6% in oxygen with a fresh gas flow rate of two
liters per minute. The sevoflurane concentration was increased
by 0.2% every 30 min until a final concentration of 4.2% was
reached. This maximal dose was maintained for an additional
30 min. The typical experiment duration was 120 min, and 1000 s
of artifact-free EEG data was selected from each rat for analysis.
IDENTIFICATION OF EEG BURSTS AND SUPPRESSIONS
Bursts and suppressions from the recorded EEG were seg-
mented using a threshold based on visual inspection. Each EEG
recording (n = 8, 1000 s each) was detrended and smoothed
by convolution with a Gaussian function, and the energy was
calculated using the nonlinear energy operator (Kaiser, 1990).
The nonlinear energy operator provides a method for clearly
separating the larger energy bursts from the lower energy
suppressions, and a visually-based threshold was set in the
energy domain to segment the data. The EEG values that
were above the threshold were classified as bursts, whereas
the values that fell below the threshold were classified as sup-
pressions. All segmentations were confirmed by one of the
authors who is an experienced clinical electroencephalographer
(MBW).
CALCULATION OF BSP
EEG segments were converted to a binary time series. Segments
that were classified as bursts were given a value of one, and
those that were classified as suppressions were given a value of
zero. The BSP algorithm used this binary time-vector to find
the instantaneous probability of burst suppression, and corre-
sponding confidence intervals (Chemali et al., 2011; Ching et al.,
Table 1 | The number of sorted individual bursts or suppressions in
each BSP bin per general anesthetic.
Propofol Sevoflurane
BSP Bursts Suppressions Bursts Suppressions
0.3–0.4 124 106 109 105
0.4–0.5 225 199 107 99
0.5–0.6 671 583 77 76
0.6–0.7 646 595 129 126
0.7–0.8 192 171 178 171
Total 1858 1654 600 577
The total number of bursts was 2,458 and the total number of suppressions was
2,231.
2013). Like the BSR, a burst suppression probability value of 1
indicates a state of complete EEG suppression, while a value of
0 indicates no suppression. Individual bursts and suppressions
from the propofol and sevoflurane EEG datasets were sorted
by their BSP into bins of 0.3–0.4, 0.4–0.5, 0.5–0.6, 0.6–0.7,
and 0.7–0.8 BSP. Bursts or suppressions that were shorter than
0.15 s were discarded, as they are too short to constitute a clear
burst or suppression. Table 1 gives the number of individual
propofol or sevoflurane-induced bursts and suppressions within
each bin.
CALCULATION OF BURST AND SUPPRESSION DURATION,
PEAK-TO-PEAK AMPLITUDE, AND POWER
Several features of each sorted individual burst (n = 2,458) and
suppression (n = 2,231) were calculated to characterize them.
Using custom scripts written in MATLAB R2013b, the duration,
peak-to-peak amplitude, and power of each individual burst
or suppression was calculated. Duration (sec) was the absolute
length of the individual burst or suppression. Peak-to-peak volt-
age (µV) was the absolute difference between the maximum
and minimum amplitude value within each individual burst or
suppression. Power (dB µV2/s) was the squared amplitude of the
individual burst or suppression divided by its own duration.
STATISTICAL ANALYSIS OF BURST AND SUPPRESSION DURATIONS,
PEAK-TO-PEAK AMPLITUDE, AND POWER
The median and accompanying 95% upper and lower confidence
intervals for the distribution of burst and suppression durations,
peak-to-peak amplitudes, and power for propofol and sevoflurane
were constructed using the percentile bootstrap procedure (Efron
and Tibshirani, 1993). Unlike hypothesis testing using p-values
alone, the usage of confidence intervals gives a measure of uncer-
tainty around the median of each feature, and testing at a 95%
level is equivalent to hypothesis testing with a significance alpha
of 0.05.
To make significance comparisons between the sevoflurane
and propofol burst suppression features, the 95% confidence
interval around the difference between sevoflurane and propofol
median values was used. If the 95% confidence intervals around
the differences are both positive then sevoflurane is considered to
be significantly higher than propofol. If both confidence intervals
are negative then propofol is considered to be significantly higher
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than sevoflurane. If one confidence interval is negative, and the
other is positive then no statistical significance can be determined.
Spectral analysis of burst suppression
Spectrograms of propofol and sevoflurane-induced burst sup-
pression were computed from EEG data using multitaper
methods from the Chronux toolbox in MATLAB R2013b
(Thomson, 1982; Mitra and Bokil, 2008; Babadi and Brown,
2014). Spectrograms were constructed using three tapers and a
two-second window stepped through 50 ms. The half-bandwidth
of the spectrogram was 1 Hz.
RESULTS
SEVOFLURANE AND PROPOFOL INDUCE DISTINCT BURST
SUPPRESSION PATTERNS
Figure 4A shows 1 min of EEG data from a rat during sevoflurane-
induced burst suppression at a BSP of approximately 0.7, and
Figure 4B shows the non-linear energy calculated from the EEG
trace in Figure 4A. Figure 4C shows 1 min of EEG data from
the same rodent during propofol-induced burst suppression at a
BSP of approximately 0.7, and Figure 4D shows the non-linear
energy calculated from the EEG trace in Figure 4C. The visually-
based threshold that was set in the energy domain to segment
data into bursts and suppressions is shown as a dotted line in
Figures 4B,D.
Figures 5A (sevoflurane) and 5B (propofol) show the time-
frequency spectrograms for five continuous minutes of burst
suppression at a BSP of 0.7 in the same rat. Warm colors
(e.g., red) show areas of high power, and cool colors (e.g.,
blue) show areas of low power. In comparison to the burst
suppression pattern induced by sevoflurane, the pattern induced
by propofol was characterized by lower power across all fre-
quency bands during both bursts and suppressions, despite
equivalent BSP.
DURATION IS SIGNIFICANTLY LONGER FOR SEVOFLURANE-INDUCED
BURSTS AND SUPPRESSIONS THAN FOR PROPOFOL-INDUCED BURSTS
AND SUPPRESSIONS ACROSS ALL BSP LEVELS
Figure 6A shows the median durations for propofol and
sevoflurane-induced bursts and suppressions separated by BSP.
For all BSP values (0.3–0.8) the median duration of sevoflurane-
induced bursts and suppressions was greater than the median
duration of propofol-induced bursts and suppressions. Table 2
shows the median burst and suppression durations at all BSP
levels (0.3–0.8) with corresponding 95% confidence intervals.
The maximum median difference between propofol and sevoflu-
rane bursts was 1.79 s at a BSP of 0.3–0.4, and the max-
imum median difference between propofol and sevoflurane
suppressions was 3.46 s at a BSP of 0.7–0.8. The minimum
median difference between propofol and sevoflurane bursts was
1.26 s at a BSP of 0.7–0.8, and the minimum median differ-
ence between propofol and sevoflurane suppressions was 0.76 s
at a BSP of 0.3–0.4. All of the confidence intervals around
the difference of medians were greater than 0, indicating that
sevoflurane bursts and suppressions were significantly longer
in duration across different BSP levels when compared to
propofol.
PEAK-TO-PEAK AMPLITUDE IS SIGNIFICANTLY HIGHER FOR
SEVOFLURANE-INDUCED BURSTS AND SUPPRESSIONS THAN
PROPOFOL-INDUCED BURSTS AND SUPPRESSIONS ACROSS ALL BSP
LEVELS
Figure 6B shows the median peak-to-peak amplitudes for
propofol and sevoflurane-induced bursts and suppressions
separated by BSP. For all BSP values (0.3–0.8) the median peak-to-
peak amplitudes of sevoflurane-induced bursts and suppressions
was greater than the median peak-to-peak amplitudes of
propofol-induced bursts and suppressions. The median burst
and suppression peak-to-peak amplitudes at all BSP values
(0.3–0.8) with corresponding 95% confidence intervals are given
in Table 2. The maximum median difference between propofol
and sevoflurane burst peak-to-peak amplitudes was 587.73 µV
at a BSP of 0.6–0.7, and the maximum median difference
between propofol and sevoflurane suppression peak-to-peak
amplitudes was 97.86 µV at a BSP of 0.6–0.7. The minimum
median difference between propofol and sevoflurane burst peak-
to-peak amplitudes was 305.02 µV at a BSP of 0.7–0.8, and the
minimum median difference between propofol and sevoflurane
suppression peak-to-peak amplitudes was 84.20 µV at a BSP of
FIGURE 4 | Representative EEG traces and energy values from the
same rat at a BSP of 0.7. (A) A 60-second EEG recording taken during
sevoflurane-induced burst suppression. Black indicates an area threshold as
suppression, and red indicates an area threshold as a burst. (B) Energy of
the EEG trace from (A) that was used to segment bursts and suppressions.
(C) 60-second EEG recording taken from the same animal during
propofol-induced burst suppression. (D) Energy of the EEG trace from (C)
shows that propofol-induced bursts and suppressions are shorter and lower
in power then sevoflurane-induced bursts and suppressions, despite an
equivalent BSP.
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FIGURE 5 | Spectrograms computed from the same rat during
5 min of burst suppression at a BSP of 0.7. Warm colors indicate
frequency components with high power, while cool colors indicate
frequency components with low power. (A) Sevoflurane-induced
burst suppression has high power between 1–10 Hz during bursts.
(B) Propofol-induced burst suppression has lower power during
bursts and suppressions across all frequencies when compared to
sevoflurane.
0.5–0.6. All of the confidence intervals around the difference of
medians were greater than 0, indicating that sevoflurane bursts
and suppressions were significantly greater in amplitude across
different BSP levels when compared with propofol.
POWER IS SIGNIFICANTLY HIGHER FOR SEVOFLURANE-INDUCED
BURSTS AND SUPPRESSIONS THAN PROPOFOL-INDUCED BURSTS
AND SUPPRESSIONS ACROSS ALL BSP LEVELS
Figure 6C shows the median power for propofol and sevoflurane-
induced bursts and suppressions separated by BSP. For all BSP
values (0.3–0.8) the median power of sevoflurane-induced bursts
and suppressions was greater than the median power of propofol-
induced bursts and suppressions. Table 2 shows the median
burst and suppression powers at all BSP values (0.3–0.8) with
corresponding 95% confidence intervals. The maximum median
difference between propofol and sevoflurane burst powers was
68.46 dB µV2/s at a BSP of 0.6–0.7, and the maximum median
difference between propofol and sevoflurane suppression powers
was 56.14 dB µV2/s at a BSP of 0.3–0.4. The minimum median
difference between propofol and sevoflurane burst powers was
64.07 dB µV2/s at a BSP of 0.7–0.8, and the minimum median
difference between propofol and sevoflurane suppression powers
was 53.65 dB µV2/s at a BSP of 0.7–0.8. All of the confidence
intervals around the difference of medians were greater than 0,
indicating that sevoflurane bursts and suppressions were signifi-
cantly larger in power across different BSP levels, when compared
with propofol.
DISCUSSION
Previous studies on burst suppression induced by general anes-
thetics have found differences between burst and suppres-
sion durations and peak-to-peak amplitudes between propofol,
etomidate, thiopental, and isoflurane in rodents, and between
propofol and isoflurane in rabbits. The inhaled anesthetic isoflu-
rane was found to produce greater amplitudes and durations
than the other intravenous agents. However, these studies only
compared a small number of individual bursts and suppressions,
and did not systematically examine them at different depths of
general anesthesia.
In this study, we gathered large amounts of EEG data during
sevoflurane and propofol anesthesia from the same animals,
and used the BSP to quantify anesthetic depth. We found that
the durations of suppressions and bursts induced by propofol
were significantly shorter than those induced by sevoflurane at all
measured levels of BSP. Additionally, the peak-to-peak amplitudes
of propofol-induced suppressions and bursts were significantly
lower than those induced by sevoflurane at all measured levels of
BSP. Sevoflurane suppressions were not completely suppressed,
as the peak-to-peak amplitudes of sevoflurane suppressions were
similar in size to the peak-to-peak amplitudes of propofol bursts.
However, it should be noted that for these experiments, we
analyzed EEG data at BSP levels ranging from 0.3–0.8. We did not
compare burst suppression patterns at BSP levels below 0.3, due
to the difficulty of visually segmenting propofol-induced bursts
and suppressions at low BSP levels.
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FIGURE 6 | Bar graphs with 95% confidence intervals for the
median duration, peak-to-peak amplitude, and power for individual
bursts and suppressions induced by propofol (blue) or sevoflurane
(red) in all animals. In order to perform direct comparisons between
the two drugs at similar depths of general anesthesia, the data was
grouped by BSP level. (A) The median durations of bursts and
suppressions were significantly longer during sevoflurane anesthesia
than during propofol anesthesia. (B) Median peak-to-peak amplitudes
(µV) were significantly greater during sevoflurane general anesthesia for
both bursts and suppressions. (C) Median power (dB µV2/s) for
individual bursts and suppressions was significantly higher during
sevoflurane general anesthesia.
Table 2 | The median differences between propofol and sevoflurane-induced bursts and suppressions for duration, peak-to-peak amplitude and
power across BSP values of 0.3–0.8.
BSP Duration Peak-to-peak Amplitude Power
Burst Suppressions Burst Suppressions Burst Suppressions
0.3–0.4 1.79 s (95% CI:
1.33–2.27 s)
0.76 s (95% CI:
0.41–1.29 s)
349.77 µV (95% CI:
322.16–386.61 µV)
90.09 µV (95% CI:
74.04–107.76 µV)
65.82 dB µV2/s (95% CI:
65.37–66.30 dB µV2/s)
56.14 dB µV2/s (95%
CI: 55.00–57.24 dB µV2/s)
0.4–0.5 1.76 s (95% CI:
1.27–2.11 s)
1.14 s (95% CI:
0.41–1.46 ss)
378.46 µV (95% CI:
347.70–407.31 µV)
94.20 µV (95% CI:
80.06–109.29 µV)
66.09 dB µV2/s (95% CI:
65.59–66.57 dB µV2/s)
55.24 dB µV2/s (95% CI:
54.63–56.33 dB µV2/s)
0.5–0.6 1.68 s (95% CI:
1.29–2.8 s)
1.79 s (95% CI:
1.06–2.66 s)
571.07 µV (95% CI:
506.36–601.20 µV)
84.20 µV (95% CI:
72.80–102.86 µV)
67.88 dB µV2/s (95% CI:
67.34–68.23 dB µV2/s)
53.89 dB µV2/s (95% CI:
52.97–54.89 dB µV2/s)
0.6–0.7 1.55 s (95% CI:
1.28–1.76 s)
2.73 s (95% CI:
2.16–3.53 s)
587.73 µV (95% CI:
553.49–646.48 µV)
97.86 µV (95% CI:
89.80–105.98 µV)
68.46 dB µV2/s (95% CI:
68.07–68.65 dB µV2/s)
53.99 dB µV2/s (95% CI:
53.50–54.45 dB µV2/s)
0.7–0.8 1.26 s (95% CI:
1.02–1.47 s)
3.46 s (95% CI:
2.69–4.36 s)
305.02 µV (95% CI:
274.58–334.39 µV)
93.75 µV (95% CI:
85.85–102.54 µV)
64.07 dB µV2/s (95% CI:
63.63–64.72 dB µV2/s)
53.65 dB µV2/s (95% CI:
52.71–54.02 dB µV2/s)
95% confidence intervals around the differences indicate if there is a significant increase, decrease, or no change between the two anesthetics. Sevoflurane-induced
bursts and suppressions are significantly greater in magnitude than propofol-induced bursts and suppressions across all BSP values for duration, peak-to-peak
amplitude, and power.
Experiments using the NMDA receptor antagonist MK801
during isoflurane-induced burst suppression showed that peak-
to-peak amplitudes and durations of bursts were diminished
compared to bursts induced by isoflurane alone, although the
rate of bursting remained the same (Kroeger and Amzica,
2007). Nitrous oxide is an NMDA antagonist (Jevtovic´-Todorovic´
et al., 1998) that decreases both suppression durations and
burst amplitudes when used as an adjunct to isoflurane gen-
eral anesthesia (Yli-Hankala et al., 1993b; Porkkala et al.,
1997). These studies suggest that NMDA receptors play an
important role in limiting the maximum amplitude of bursts
and suppressions. However, in the present study we found
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that sevoflurane induced greater durations and amplitudes
for both bursts and suppressions when compared to propo-
fol, even though sevoflurane inhibits NMDA receptors, and
propofol is thought to act primarily via GABAA receptors
(Solt and Forman, 2007). Our results demonstrate that NMDA
receptor pharmacology alone does not account for the differ-
ent burst suppression patterns observed with sevoflurane and
propofol.
Extracellular calcium or ATP reuptake may also modulate the
durations of bursts and suppressions. An increase in the rate
of ATP reuptake under propofol (when compared to sevoflu-
rane) could increase the rate of switching between bursts and
suppressions. Cerebral blood flow could also be an important
factor that determines the duration of bursts and suppressions
(Kroeger and Amzica, 2007; Ching et al., 2012). It has also been
suggested that during the state of burst suppression the cortex
is more sensitive to external stimuli, since such stimuli have
been shown to trigger bursts under isoflurane anesthesia (Hudetz
and Imas, 2007). The cortex may be more sensitive to external
stimuli during propofol-induced burst suppression compared to
sevoflurane-induced burst suppression, allowing bursts to occur
with greater frequency (Ferron et al., 2009). Despite equivalent
global reduction in the CMRO, regional variations in CMRO
reduction could account for the differences in burst suppres-
sion patterns observed between two different general anesthetics
(Akrawi et al., 1996; Ching et al., 2012). In vitro studies of
thiopental, propofol, and isoflurane show that these anesthetics
potentiate GABAA receptors. The activation of these receptors
leads to a burst suppression pattern, and further increasing the
anesthetic concentration depresses glutamatergic transmission.
This decrease in glutamatergic transmission will eventually lead
to complete suppression of the EEG. (Lukatch and Maciver, 1996;
Lukatch et al., 2005).
Traditionally, the period of suppression is thought to be one of
electrical silence. In the present study at 0.5 BSP, the median peak-
to-peak amplitude of sevoflurane suppressions was 136 µV (95%
CI: 125–155 µV), whereas the median peak-to-peak amplitude
of propofol suppressions was only 52 µV (95% CI: 51–53 µV).
In fact, the median peak-to-peak amplitude of propofol bursts
(196 µV, 95% CI: 187–213 µV) was similar in magnitude to
the median peak-to-peak amplitude of sevoflurane suppressions.
This illustrates why visual thresholding was necessary for this
study.
The high suppression amplitudes that we observed for sevoflu-
rane have also been described for another halogenated ether anes-
thetic, isoflurane (Akrawi et al., 1996). This suggests that a greater
level of neuronal activity occurs during suppressions induced
by sevoflurane and isoflurane when compared to intravenous
anesthetics such as propofol and barbiturates. It is known that
during urethane and xylazine anesthesia, thalamic neurons fire
at a steady delta rhythm (1–4 Hz) during suppression (Steriade
et al., 1994). Future studies are needed to test whether thalamic
firing activity is greater during EEG suppression periods induced
by inhaled ether anesthetics.
Burst suppression is generally viewed as a single phenomenon
that can be induced by various pathological processes as well
as general anesthetics. However, the present results demonstrate
that even after controlling for the depth of general anesthesia,
different general anesthetics induce very different patterns of
burst suppression. Automated algorithms used to segment burst
suppression need to be tuned to match specific general anesthetics
by taking into account the large differences in amplitudes and
durations. More studies are needed to elucidate the underlying
physiology that governs the burst suppression features induced by
different general anesthetics.
DISCLOSURE OF FUNDING
This research was supported by grants TR01-GM104948 and
K08-GM094394 from the National Institutes of Health, Bethesda,
Maryland.
REFERENCES
Aicardi, J. (2005). Aicardi syndrome. Brain Dev. 27, 164–171. doi: 10.1016/j.
braindev.2003.11.011
Aicardi, J., and Ohtahara, S. (2005). “Severe neonatal epilepsies with suppression-
burst pattern,” in Epileptic Syndromes in Infancy, Childhood and Adolescence 4th
Edn., eds J. Roger, M. Bureau, C. Dravet and P. Genton (London: John Libbey),
39–52.
Akrawi, W. P., Drummond, J. C., Kalkman, C. J., and Patel, P. M. (1996). A
comparison of the electrophysiologic characteristics of EEG burst-suppression
as produced by isoflurane, thiopental, etomidate and propofol. J. Neurosurg.
Anesthesiol. 8, 40–46. doi: 10.1097/00008506-199601000-00010
Amzica, F. (2009). Basic physiology of burst-suppression. Epilepsia 50(Suppl. 12),
38–39. doi: 10.1111/j.1528-1167.2009.02345.x
Arrica, M., and Bissonnette, B. (2007). Therapeutic hypothermia. Semin. Cardio-
thorac. Vasc. Anesth. 11, 6–15. doi: 10.1177/1089253206297409
Auer, R. N., Olsson, Y., and Siesjö, B. K. (1984). Hypoglycemic brain injury
in the rat. Correlation of density of brain damage with the EEG isoelec-
tric time: a quantitative study. Diabetes 33, 1090–1098. doi: 10.2337/diab.33.
11.1090
Babadi, B., and Brown, E. N. (2014). A review of multi-taper analysis. IEEE Trans.
Biomed. Eng. 61, 1555–1564. doi: 10.1109/TBME.2014.2311996
Barash, P. G., Cullen, B. F., Stoelting, R. K., Cahalan, M., and Stock, M. C. (2012).
Clinical Anesthesia. Philadelphia, PA: Lippincott Williams and Wilkins.
Beydoun, A., Yen, C. E., and Drury, I. (1991). Variance of interburst intervals in
burst suppression. Electroencephalogr. Clin. Neurophysiol. 79, 435–439. doi: 10.
1016/0013-4694(91)90162-w
Bickford, R. G., and Butt, H. R. (1955). Hepatic coma: the electroencephalographic
pattern. J. Clin. Invest. 34, 790–799. doi: 10.1172/jci103134
Brown, E. N., Lydic, R., and Schiff, N. D. (2010). General anesthesia, sleep and
coma. N. Engl. J. Med. 363, 2638–2650. doi: 10.1056/NEJMra0808281
Brown, E. N., Purdon, P. L., and Van Dort, C. J. (2011). General anesthesia and
altered states of arousal: a systems neuroscience analysis. Annu. Rev. Neurosci.
34, 601–628. doi: 10.1146/annurev-neuro-060909-153200
Bruhn, J., Bouillon, T. W., and Shafer, S. L. (2001). Onset of propofol-induced
burst suppression may be correctly detected as deepening of anaesthesia by
approximate entropy but not by bispectral index. Br. J. Anaesth. 87, 505–507.
doi: 10.1093/bja/87.3.505
Bruhn, J., Ropcke, H., Rehberg, B., Bouillon, T., and Hoeft, A. (2000). Electroen-
cephalogram approximate entropy correctly classifies the occurrence of burst
suppression pattern as increasing anesthetic drug effect. Anesthesiology 93, 981–
985. doi: 10.1097/00000542-200010000-00018
Chemali, J., Ching, S., Purdon, P. L., Solt, K., and Brown, E. N. (2013). Burst
suppression probability algorithms: state-space methods for tracking EEG
burst suppression. J. Neural Eng. 10:056017. doi: 10.1088/1741-2560/10/5/05
6017
Chemali, J. J., Van Dort, C. J., Brown, E. N., and Solt, K. (2012). Active emergence
from propofol general anesthesia is induced by methylphenidate. Anesthesiology
116, 998–1005. doi: 10.1097/ALN.0b013e3182518bfc
Chemali, J. J., Wong, K. F., Solt, K., and Brown, E. N. (2011). A state-space model
of the burst suppression ratio. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2011, 1431–
1434. doi: 10.1109/IEMBS.2011.6090354
Frontiers in Systems Neuroscience www.frontiersin.org December 2014 | Volume 8 | Article 237 | 10
Kenny et al. Burst suppression: a review and new insights
Ching, S., Liberman, M. Y., Chemali, J. J., Westover, M. B., Kenny, J. D., Solt, K., et al.
(2013). Real-time closed-loop control in a rodent model of medically induced
coma using burst suppression. Anesthesiology 119, 848–860. doi: 10.1097/ALN.
0b013e31829d4ab4
Ching, S., Purdon, P. L., Vijayan, S., Kopell, N. J., and Brown, E. N. (2012). A
neurophysiological-metabolic model for burst suppression. Proc. Natl. Acad. Sci.
U S A 109, 3095–3100. doi: 10.1073/pnas.1121461109
Claassen, J., Hirsch, L. J., Emerson, R. G., and Mayer, S. A. (2002). Treatment
of refractory status epilepticus with pentobarbital, propofol, or midazolam:
a systematic review. Epilepsia 43, 146–153. doi: 10.1046/j.1528-1157.2002.
28501.x
Cotten, J. F., Le Ge, R., Banacos, N., Pejo, E., Husain, S. S., Williams, J. H.,
et al. (2011). Closed-loop continuous infusions of etomidate and etomidate
analogs in rats: a comparative study of dosing and the impact on adreno-
cortical function. Anesthesiology 115, 764–773. doi: 10.1097/ALN.0b013e3182
1950de
Derbyshire, A. J., Rempel, B., Forbes, A., and Lambert, E. (1936). The effects of
anesthetics on action potentials in the cerebral cortex of the cat. Am. J. Physiol.
Leg. Content 116, 577–596.
De Rubeis, D. A., and Young, G. B. (2001). Continuous EEG monitoring in a
patient with massive carbamazepine overdose. J. Clin. Neurophysiol. 18, 166–
168. doi: 10.1097/00004691-200103000-00008
Dow, R. S. (1961). The electroencephalographic findings in acute intermittent por-
phyria. Electroencephalogr. Clin. Neurophysiol. 13, 425–437. doi: 10.1016/0013-
4694(61)90011-6
Doyle, P. W., and Matta, B. F. (1999). Burst suppression or isoelectric encephalo-
gram for cerebral protection: evidence from metabolic suppression studies. Br.
J. Anaesth. 83, 580–584. doi: 10.1093/bja/83.4.580
Efron, B., and Tibshirani, R. (1993). An Introduction to the Bootstrap. Boca Raton,
FL: CRC press.
Engelhardt, W., Carl, G., and Hartung, E. (1993). Intra-individual open com-
parison of burst-suppression-isoflurane-anaesthesia versus electroconvulsive
therapy in the treatment of severe depression. Eur. J. Anaesthesiol. 10,
113–118.
Fariello, R. G., Chun, R. W., Doro, J. M., Buncic, J. R., and Prichard, J. S. (1977).
EEG recognition of Aicardi’s syndrome. Arch. Neurol. 34, 563–566. doi: 10.
1001/archneur.1977.00500210065012
Ferenets, R., Lipping, T., Suominen, P., Turunen, J., Puumala, P., Jantti, V., et al.
(2006). “Comparison of the properties of EEG spindles in sleep and propofol
anesthesia,” in Engineering in Medicine and Biology Society, 2006. EMBS′06.
28th Annual International Conference of the IEEE. (New York, NY: IEEE),
6356–6359.
Ferron, J. F., Kroeger, D., Chever, O., and Amzica, F. (2009). Cortical inhibition
during burst suppression induced with isoflurane anesthesia. J. Neurosci. 29,
9850–9860. doi: 10.1523/JNEUROSCI.5176-08.2009
Grigg-Damberger, M. M., Coker, S. B., Halsey, C. L., and Anderson, C. L. (1989).
Neonatal burst suppression: its developmental significance. Pediatr. Neurol. 5,
84–92. doi: 10.1016/0887-8994(89)90032-5
Hartikainen, K., Rorarius, M., Mäkelä, K., Yli-Hankala, A., and Jäntti, V. (1995a).
Propofol and isoflurane induced EEG burst suppression patterns in rab-
bits. Acta Anaesthesiol. Scand. 39, 814–818. doi: 10.1111/j.1399-6576.1995.tb
s04176.x
Hartikainen, K. M., Rorarius, M., Peräkylä, J. J., Laippala, P. J., and Jäntti, V.
(1995b). Cortical reactivity during isoflurane burst-suppression anesthesia.
Anesth. Analg. 81, 1223–1228. doi: 10.1097/00000539-199512000-00018
Hellström-Westas, L., Rosén, I., and Svenningsen, N. W. (1995). Predictive value of
early continuous amplitude integrated EEG recordings on outcome after severe
birth asphyxia in full term infants. Arch. Dis. Child. Fetal Neonatal. Ed. 72, F34–
F38. doi: 10.1136/fn.72.1.f34
Henry, C. E., and Scoville, W. B. (1952). Suppression-burst activity from isolated
cerebral cortex in man. Electroencephalogr. Clin. Neurophysiol. 4, 1–22. doi: 10.
1016/0013-4694(52)90027-8
Hofmeijer, J., Tjepkema-Cloostermans, M. C., and van Putten, M. J. (2014). Burst-
suppression with identical bursts: a distinct EEG pattern with poor outcome in
postanoxic coma. Clin. Neurophysiol. 125, 947–954. doi: 10.1016/j.clinph.2013.
10.017
Hudetz, A. G., and Imas, O. A. (2007). Burst activation of the cerebral cortex by
flash stimuli during isoflurane anesthesia in rats. Anesthesiology 107, 983–991.
doi: 10.1097/01.anes.0000291471.80659.55
Huotari, A. M., Koskinen, M., Suominen, K., Alahuhta, S., Remes, R., Hartikainen,
K. M., et al. (2004). Evoked EEG patterns during burst suppression with
propofol. Br. J. Anaesth. 92, 18–24. doi: 10.1093/bja/aeh022
Itoh, M., Hanaoka, S., Sasaki, M., Ohama, E., and Takashima, S. (2001). Neu-
ropathology of early-infantile epileptic encephalopathy with suppression-bursts;
comparison with those of early myoclonic encephalopathy and west syndrome.
Brain Dev. 23, 721–726. doi: 10.1016/s0387-7604(01)00270-4
Jevtovic´-Todorovic´, V., Todorovc´, S., Mennerick, S., Powell, S., Dikranian, K.,
Benshoff, N., et al. (1998). Nitrous oxide (laughing gas) is an NMDA antagonist,
neuroprotectant and neurotoxin. Nat. Med. 4, 460–463. doi: 10.1038/nm0498-
460
Kaiser, J. F. (1990). “On a simple algorithm to calculate theenergy’of a signal,”
in Acoustics, Speech and Signal Processing, 1990. ICASSP-90., 1990 International
Conference on. (Albuquerque, NM: IEEE), 381–384.
Kassell, N. F., Hitchon, P. W., Gerk, M. K., Sokoll, M. D., and Hill, T. R. (1980).
Alterations in cerebral blood flow, oxygen metabolism and electrical activity
produced by high dose sodium thiopental. Neurosurgery 7, 598–603. doi: 10.
1097/00006123-198012000-00011
Kheder, A., Bianchi, M. T., and Westover, M. B. (2014). Burst suppression in sleep
in a routine outpatient EEG. Epilepsy Behav. Case Rep. 2, 71–74. doi: 10.1016/j.
ebcr.2014.01.003
Kroeger, D., and Amzica, F. (2007). Hypersensitivity of the anesthesia-induced
comatose brain. J. Neurosci. 27, 10597–10607. doi: 10.1523/jneurosci.3440-07.
2007
Lambrakis, C. C., Lancman, M. E., and Romano, C. (1999). Asynchronous and
asymmetric burst-suppression in a patient with a corpus callosum lesion. Clin.
Neurophysiol. 110, 103–105. doi: 10.1016/s0013-4694(98)00102-3
Lazar, L. M., Milrod, L. M., Solomon, G. E., and Labar, D. R. (1999). Asynchronous
pentobarbital-induced burst suppression with corpus callosum hemorrhage.
Clin. Neurophysiol. 110, 1036–1040. doi: 10.1016/s1388-2457(99)00046-2
Lebowitz, M. H., Blitt, C. D., and Dillon, J. B. (1972). Enflurane-induced central
nervous system excitation and its relation to carbon dioxide tension. Anesth.
Analg. 51, 355–363. doi: 10.1213/00000539-197205000-00007
Levy, W. J. (1984). Quantitative analysis of EEG changes during hypothermia.
Anesthesiology 60, 291–297. doi: 10.1097/00000542-198404000-00004
Lewis, L. D., Ching, S., Weiner, V. S., Peterfreund, R. A., Eskandar, E. N., Cash, S. S.,
et al. (2013). Local cortical dynamics of burst suppression in the anaesthetized
brain. Brain 136, 2727–2737. doi: 10.1093/brain/awt174
Liley, D. T., and Walsh, M. (2013). The Mesoscopic modeling of burst suppression
during anesthesia. Front. Comput. Neurosci. 7:46. doi: 10.3389/fncom.2013.
00046
Lipping, T., Jäntti, V., Yli-Hankala, A., and Hartikainen, K. (1995). Adaptive seg-
mentation of burst-suppression pattern in isoflurane and enflurane anesthesia.
Int. J. Clin. Monit. Comput. 12, 161–167. doi: 10.1007/bf02332690
Löfhede, J., Löfgren, N., Thordstein, M., Flisberg, A., Kjellmer, I., and Lindecrantz,
K. (2007). Comparison of three methods for classifying burst and suppression in
the EEG of post asphyctic newborns. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007,
5136–5139. doi: 10.1109/iembs.2007.4353496
Lowenstein, D. H., Bleck, T., and Macdonald, R. L. (1999). It’s time to revise the
definition of status epilepticus. Epilepsia 40, 120–122. doi: 10.1111/j.1528-1157.
1999.tb02000.x
Lukatch, H. S., Echon, R. M., Maciver, M. B., and Werchan, P. M. (1997). G-
force induced alterations in rat EEG activity: a quantitative analysis. Elec-
troencephalogr. Clin. Neurophysiol. 103, 563–573. doi: 10.1016/s0013-4694(97)
00063-1
Lukatch, H. S., Kiddoo, C. E., and Maciver, M. B. (2005). Anesthetic-induced
burst suppression EEG activity requires glutamate-mediated excitatory synaptic
transmission. Cereb. Cortex 15, 1322–1331. doi: 10.1093/cercor/bhi015
Lukatch, H. S., and Maciver, M. B. (1996). Synaptic mechanisms of thiopental-
induced alterations in synchronized cortical activity. Anesthesiology 84, 1425–
1434. doi: 10.1097/00000542-199606000-00019
Martin, J. T., Faulconer, A. Jr., and Bickford, R. G. (1959). Electroencephalog-
raphy in anesthesiology. Anesthesiology 20, 359–376. doi: 10.1097/00000542-
195905000-00017
Michenfelder, J. D., and Milde, J. H. (1991). The relationship among canine brain
temperature, metabolism and function during hypothermia. Anesthesiology 75,
130–136. doi: 10.1097/00000542-199107000-00021
Mitra, P., and Bokil, H. (2008). Observed Brain Dynamics. Oxford; New York:
Oxford University Press.
Frontiers in Systems Neuroscience www.frontiersin.org December 2014 | Volume 8 | Article 237 | 11
Kenny et al. Burst suppression: a review and new insights
Modica, P. A., and Tempelhoff, R. (1992). Intracranial pressure during induction
of anaesthesia and tracheal intubation with etomidate-induced EEG burst
suppression. Can. J. Anaesth. 39, 236–241. doi: 10.1007/bf03008783
Morris, L. E., Knott, J. R., and Pittinger, C. B. (1955). Electro-encephalographic
and blood gas observations in human surgical patients during xenon
anesthesia. Anesthesiology 16, 312–319. doi: 10.1097/00000542-195505000-
00003
Mundi, J. P., Betancourt, J., Ezziddin, O., Tremayne, B., Majic, T., and Mosenifar,
Z. (2012). Dilated and unreactive pupils and burst-suppression on electroen-
cephalography due to buproprion overdose. J. Intensive Care Med. 27, 384–388.
doi: 10.1177/0885066611429661
Murrell, J. C., Waters, D., and Johnson, C. B. (2008). Comparative effects of
halothane, isoflurane, sevoflurane and desflurane on the electroencephalogram
of the rat. Lab. Anim. 42, 161–170. doi: 10.1258/la.2007.06019e
Nims, L. F., Marshall, C., and Nielsen, A. (1941). Effect of local freezing on the
electrical activity of the cerebral cortex. Yale J. Biol. Med. 13, 477–484.
Ohtahara, S., and Yamatogi, Y. (2003). Epileptic encephalopathies in early
infancy with suppression-burst. J. Clin. Neurophysiol. 20, 398–407. doi: 10.
1097/00004691-200311000-00003
Ohtahara, S., and Yamatogi, Y. (2006). Ohtahara syndrome: with special ref-
erence to its developmental aspects for differentiating from early myoclonic
encephalopathy. Epilepsy Res. 70(Suppl. 1), S58–S67. doi: 10.1016/j.eplepsyres.
2005.11.021
Ostermann, M. E., Young, B., Sibbald, W. J., and Nicolle, M. W. (2000). Coma
mimicking brain death following baclofen overdose. Intensive Care Med. 26,
1144–1146. doi: 10.1007/s001340051330
Panayiotopoulos, C. P. (2010). Atlas of Epilepsies. London: Springer, 847–850.
doi: 10.1007/978-1-84882-128-6_120
Pearcy, W. C., Knott, J. E., Pittinger, C. B., and Keasling, H. H. (1957). Elec-
troencephalographic and circulatory effects of chloroform anesthesia in dogs.
Anesthesiology 18, 88–96. doi: 10.1097/00000542-195701000-00009
Pittinger, C. B., Faulconer, A. Jr., Knott, J. R., Pender, J. W., Morris, L. E., and
Bickford, R. G. (1955). Electro-encephalographic and other observations in
monkeys during xenon anesthesia at elevated pressures. Anesthesiology 16, 551–
563. doi: 10.1097/00000542-195507000-00011
Porkkala, T., Jänit, V., Kaukinen, S., and Häkkinen, V. (1997). Nitrous oxide
has different effects on the EEG and somatosensory evoked potentials during
isoflurane anaesthesia in patients. Acta Anaesthesiol. Scand. 41, 497–501. doi: 10.
1111/j.1399-6576.1997.tb04730.x
Possati, S., Faulconer, A. Jr., Bickford, R. G., and Hunter, R. C. (1953). Electroen-
cephalographic patterns during anesthesia with cyclopropane: correlation with
concentration of cyclopropane in arterial blood. Curr. Res. Anesth. Analg. 32,
130–135. doi: 10.1213/00000539-195301000-00022
Prasad, A., Worrall, B. B., Bertram, E. H., and Bleck, T. P. (2001). Propofol and
midazolam in the treatment of refractory status epilepticus. Epilepsia 42, 380–
386. doi: 10.1046/j.1528-1157.2001.27500.x
Prerau, M. J., and Purdon, P. L. (2013). “A probabilistic framework for time-
frequency detection of burst suppression,” in Neural Engineering (NER),
2013 6th International IEEE/EMBS Conference on. (San Diego, CA: IEEE),
609–612.
Rae-Grant, A. D., and Kim, Y. W. (1994). Type III intermittency: a nonlinear
dynamic model of EEG burst suppression. Electroencephalogr. Clin. Neurophys-
iol. 90, 17–23. doi: 10.1016/0013-4694(94)90109-0
Rampil, I. J., Lockhart, S. H., Eger, E. I. 2nd, Yasuda, N., Weiskopf, R. B.,
and Cahalan, M. K. (1991). The electroencephalographic effects of desflurane
in humans. Anesthesiology 74, 434–439. doi: 10.1097/00000542-199103000-
00008
Rampil, I. J., Weiskopf, R. B., Brown, J. G., Eger, E. I. 2nd, Johnson, B. H., Holmes,
M. A., et al. (1988). I653 and isoflurane produce similar dose-related changes
in the electroencephalogram of pigs. Anesthesiology 69, 298–302. doi: 10.
1097/00000542-198809000-00002
Särkelä, M., Mustola, S., Seppänen, T., Koskinen, M., Lepola, P., Suominen,
K., et al. (2002). Automatic analysis and monitoring of burst suppression
in anesthesia. J. Clin. Monit. Comput. 17, 125–134. doi: 10.1023/A:10163939
04439
Scheller, M. S., Nakakimura, K., Fleischer, J. E., and Zornow, M. H. (1990). Cerebral
effects of sevoflurane in the dog: comparison with isoflurane and enflurane. Br.
J. Anaesth. 65, 388–392. doi: 10.1093/bja/65.3.388
Shanechi, M. M., Chemali, J. J., Liberman, M., Solt, K., and Brown, E. N. (2013a).
A brain-machine interface for control of burst suppression in medical coma.
Conf. Proc. IEEE Eng. Med. Biol. Soc. 2013, 1575–1578. doi: 10.1109/EMBC.2013.
6609815
Shanechi, M. M., Chemali, J. J., Liberman, M., Solt, K., and Brown, E. N. (2013b). A
brain-machine interface for control of medically-induced coma. PLoS Comput.
Biol. 9:e1003284. doi: 10.1371/journal.pcbi.1003284
Solt, K., Cotten, J. F., Cimenser, A., Wong, K. F., Chemali, J. J., and
Brown, E. N. (2011). Methylphenidate actively induces emergence from gen-
eral anesthesia. Anesthesiology 115, 791–803. doi: 10.1097/ALN.0b013e31822
e92e5
Solt, K., Eger, E. I., and Raines, D. E. (2006). Differential modulation of
human N-methyl-D-aspartate receptors by structurally diverse general anes-
thetics. Anesth. Analg. 102, 1407–1411. doi: 10.1213/01.ane.0000204252.
07406.9f
Solt, K., and Forman, S. A. (2007). Correlating the clinical actions and molecu-
lar mechanisms of general anesthetics. Curr. Opin. Anaesthesiol. 20, 300–306.
doi: 10.1097/aco.0b013e32816678a5
Sonkajärvi, E., Puumala, P., Erola, T., Baer, G., Karvonen, E., Suominen, K., et al.
(2008). Burst suppression during propofol anaesthesia recorded from scalp and
subthalamic electrodes: report of three cases. Acta Anaesthesiol. Scand. 52, 274–
279. doi: 10.1111/j.1399-6576.2007.01501.x
Spoerel, W. E. (1961). The electroencephalogram as indicator of hypoxia. Anesth.
Analg. 40, 94–104. doi: 10.1213/00000539-196101000-00013
Stecker, M. M., Cheung, A. T., Pochettino, A., Kent, G. P., Patterson, T., Weiss,
S. J., et al. (2001). Deep hypothermic circulatory arrest: I. Effects of cooling
on electroencephalogram and evoked potentials. Ann. Thorac. Surg. 71, 14–21.
doi: 10.1016/s0003-4975(00)01592-7
Stecker, M. M., Kramer, T. H., Raps, E. C., O’Meeghan, R., Dulaney, E., and Skaar,
D. J. (1998). Treatment of refractory status epilepticus with propofol: clinical
and pharmacokinetic findings. Epilepsia 39, 18–26. doi: 10.1111/j.1528-1157.
1998.tb01269.x
Steriade, M., Amzica, F., and Contreras, D. (1994). Cortical and thala-
mic cellular correlates of electroencephalographic burst-suppression. Elec-
troencephalogr. Clin. Neurophysiol. 90, 1–16. doi: 10.1016/0013-4694(94)
90108-2
Swank, R. L., and Watson, C. W. (1949). Effects of barbiturates and ether
on spontaneous electrical activity of dog brain. J. Neurophysiol. 12,
137–160.
Thadani, H., Deacon, A., and Peters, T. (2000). Diagnosis and management of
porphyria. BMJ 320, 1647–1651. doi: 10.1136/bmj.320.7250.1647
Thomson, D. J. (1982). Spectrum estimation and harmonic-analysis. Proc. IEEE 70,
1055–1096. doi: 10.1109/proc.1982.12433
Toet, M. C., Hellstrom-Westas, L., Groenendaal, F., Eken, P., and de Vries, L. S.
(1999). Amplitude integrated EEG 3 and 6 hours after birth in full term neonates
with hypoxic-ischaemic encephalopathy. Arch. Dis. Child. Fetal Neonatal. Ed. 81,
F19–F23. doi: 10.1136/fn.81.1.f19
Van Ness, P. C. (1990). Pentobarbital and EEG burst suppression in treatment of
status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 31, 61–
67. doi: 10.1111/j.1528-1157.1990.tb05361.x
van Rooij, L. G., Toet, M. C., Osredkar, D., van Huffelen, A. C., Groenendaal, F., and
de Vries, L. S. (2005). Recovery of amplitude integrated electroencephalographic
background patterns within 24 hours of perinatal asphyxia. Arch. Dis. Child.
Fetal Neonatal. Ed. 90, F245–F251. doi: 10.1136/adc.2004.064964
Vijn, P. C., and Sneyd, J. R. (1998). I.v. anaesthesia and EEG burst suppression
in rats: bolus injections and closed-loop infusions. Br. J. Anaesth. 81, 415–421.
doi: 10.1093/bja/81.3.415
Weissenborn, K., Wilkens, H., Hausmann, E., and Degen, P. H. (1991). Burst
suppression EEG with baclofen overdose. Clin. Neurol. Neurosurg. 93, 77–80.
doi: 10.1016/0303-8467(91)90015-h
Wennberg, R., Quesney, F., Olivier, A., and Dubeau, F. (1997). Induction of
burst-suppression and activation of epileptiform activity after methohexital and
selective amygdalo-hippocampectomy. Electroencephalogr. Clin. Neurophysiol.
102, 443–451. doi: 10.1016/s0921-884x(97)96052-5
Westover, M. B., Shafi, M. M., Ching, S., Chemali, J. J., Purdon, P. L., Cash,
S. S., et al. (2013). Real-time segmentation of burst suppression patterns in
critical care EEG monitoring. J. Neurosci. Methods 219, 131–141. doi: 10.1016/j.
jneumeth.2013.07.003
Frontiers in Systems Neuroscience www.frontiersin.org December 2014 | Volume 8 | Article 237 | 12
Kenny et al. Burst suppression: a review and new insights
Whishaw, I. Q. (1976). The effects of alcohol and atropine on EEG and behavior in
the rabbit. Psychopharmacology (Berl) 48, 83–90. doi: 10.1007/bf00423311
Yli-Hankala, A., Jäntti, V., Pyykko, I., and Lindgren, L. (1993a). Vibration stimulus
induced EEG bursts in isoflurane anaesthesia. Electroencephalogr. Clin. Neuro-
physiol. 87, 215–220. doi: 10.1016/0013-4694(93)90021-m
Yli-Hankala, A., Lindgren, L., Porkkala, T., and Jäntti, V. (1993b). Nitrous oxide-
mediated activation of the EEG during isoflurane anaesthesia in patients. Br. J.
Anaesth. 70, 54–57. doi: 10.1093/bja/70.1.54
Young, G. B. (2000). The EEG in coma. J. Clin. Neurophysiol. 17, 473–485. doi: 10.
1097/00004691-200009000-00006
Young, G. B., Bolton, C. F., Archibald, Y. M., Austin, T. W., and Wells, G. A.
(1992). The electroencephalogram in sepsis-associated encephalopathy. J. Clin.
Neurophysiol. 9, 145–152. doi: 10.1097/00004691-199201000-00016
Zaret, B. S. (1985). Prognostic and neurophysiological implications of concurrent
burst suppression and alpha patterns in the EEG of post-anoxic coma. Electroen-
cephalogr. Clin. Neurophysiol. 61, 199–209. doi: 10.1016/0013-4694(85)91085-5
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 15 August 2014; accepted: 27 November 2014; published online: 18 December
2014.
Citation: Kenny JD, Westover MB, Ching S, Brown EN and Solt K (2014) Propofol and
sevoflurane induce distinct burst suppression patterns in rats. Front. Syst. Neurosci.
8:237. doi: 10.3389/fnsys.2014.00237
This article was submitted to the journal Frontiers in Systems Neuroscience.
Copyright © 2014 Kenny, Westover, Ching, Brown and Solt. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution and reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Systems Neuroscience www.frontiersin.org December 2014 | Volume 8 | Article 237 | 13
